Related Experiment Video
Updated: Jul 6, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Chemoprevention of breast cancer
Aurelio B Castrellon1, Stefan Glück
1University of Miami Miller's School Of Medicine, Division of Hematology/Medical Oncology, Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue Miami, FL 33136, USA. acastrellon1@med.miami.edu
Abstract:
Breast cancer remains the second leading cause of malignancy-related death in women in the USA, regardless of advances in novel therapeutic agents. High priority should be given to research aimed at the study of pharmacological and natural compounds that could potentially prevent the development of breast cancer in susceptible patients. Tamoxifen has been shown to reduce the incidence of estrogen receptor-positive invasive breast cancer in women with a high risk of developing this condition by nearly 50%, and studies in osteoporosis have revealed a similar protective effect of raloxifene in postmenopausal women. The aromatase inhibitors are superior to tamoxifen in reducing the recurrence of breast cancer in postmenopausal women; large clinical trials are currently evaluating the chemopreventive effect of these agents. The list of agents with the potential for chemoprevention in breast cancer is extensive and continues to expand. There is an immense need to develop drugs that will decrease the incidence of estrogen receptor-negative breast cancer in women at high risk of developing the disease. Herein, we review the most important chemopreventive agents in breast cancer and clinical trials that have evaluated their efficacy.
Insights
Preventing breast cancer is crucial. This review covers key chemopreventive agents and clinical trials, highlighting progress in reducing cancer incidence, especially for estrogen receptor-negative types.
Area of Science:
- Oncology
- Pharmacology
- Preventive Medicine
Background:
- Breast cancer is a leading cause of death in women, necessitating research into preventive strategies.
- Existing therapies like tamoxifen and aromatase inhibitors show promise, particularly for estrogen receptor-positive breast cancer.
- There is a critical need for effective chemoprevention, especially for estrogen receptor-negative breast cancer.
Purpose of the Study:
- To review significant chemopreventive agents for breast cancer.
- To summarize clinical trials evaluating the efficacy of these agents.
- To highlight progress and future directions in breast cancer chemoprevention.
Main Methods:
- Literature review of pharmacological and natural compounds for breast cancer prevention.
- Analysis of clinical trial data on the efficacy of various chemopreventive agents.
- Focus on agents targeting both estrogen receptor-positive and estrogen receptor-negative breast cancer.
Main Results:
- Tamoxifen reduces estrogen receptor-positive invasive breast cancer incidence by nearly 50% in high-risk women.
- Aromatase inhibitors demonstrate superiority over tamoxifen in reducing recurrence in postmenopausal women.
- Ongoing clinical trials are evaluating the chemopreventive effects of multiple agents.
Conclusions:
- Chemoprevention plays a vital role in reducing breast cancer incidence and recurrence.
- Further research is essential to develop novel agents, particularly for estrogen receptor-negative breast cancer.
- The landscape of breast cancer chemoprevention is expanding with promising therapeutic options.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
